A clinical study to evaluate the efficacy of Lightinderm device augmented spot corrector serum use in reducing the hyperpigmented spots in healthy female subjects - NI

ightinderm0 个研究点目标入组 0 人开始时间: 待定最近更新: 2023年9月18日

试验速览

暂无简介。

•1.Female adult subjects in general good health as determined from a recent medical history, general physical examination, dermatological assessment.
•2.Subjects in the age group of 18-50 years (both ages inclusive).
•3.Subjects with various skin types, including normal, dry, oily, and combination, while excluding those with sensitive skin.
•4.Subjects with skin phototype III to VI
•5.Subjects presenting with uneven skin tone and hyperpigmented spots on the face with a subset of 10 subjects with melasma
•6.Subjects free of excessive hair, acne, cuts, abrasions, fissures, wounds, lacerations, or any other active skin conditions on the face as determined by the dermatologist.
•7.Subject who agrees not to use any other product/treatment/home remedy/ except the provided product on their face during the study period other than the test and additional products of the study.
•8.Subjects who agree not to carry out bleaching or any other procedures including facial etc. on face during the study period.
•9.Subjects who agree not to expose to excessive sun light (sun exposure not more than half an hour daily and during that time use of umbrella to cover face).
•10.Subjects willing to give a voluntary written informed consent, photography release and agree to come for regular follow-up.
•11.Subjects willing to abide by and comply with the study protocol.

•1.Subject with any other signs of significant local irritation or skin disease.
•2.Subject currently taking any medication, which the Investigator believes may influence the interpretation of the data.
•3.Subject having clinically significant systemic or cutaneous disease, chronic illness or had major surgery in the last year.
•4.Subjects who do not agree to remove all jewellery on/around face (e.g., necklace, earrings, if possible nose ring), during VISIA CR imaging.
•5.Subjects having hair style which covers almost the entire forehead
•6.Subjects undergoing any treatment of any skin condition on their face
•7.Subjects not willing to discontinue other topical facial products.
•8.Subject allergic or sensitive to bar, cleansing products, cosmetics, creams/lotions, artificial jewellery or anything else.
•9.Subjects who are pregnant and lactating
•10.Subjects on any medical treatment either systemic/topical in the past 1 month or currently taking medication including food supplements.
•11.Subjects with skin allergy, history of atopic dermatitis or psoriasis
•12.Subjects who have participated in any other clinical trial in the last 3 months.
•13.Subjects who have undergone treatment with Botox/filler /bio stimulatory molecules injection in the past six months.

发起方

ightinderm